Barnes, TRE, Banerjee, S, Collins, N, et al (2012) Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. British Journal of Psychiatry, 201: 221–6.
Berwick, DM, Hackbarth, AD (2012) Eliminating waste in US health care. JAMA, 307: 1513–6.
Brunet, M (2014) Targets for dementia diagnoses will lead to overdiagnosis. BMJ, 348: g2224.
Burns, T (2014) Our Necessary Shadow: The Nature and Meaning of Psychiatry.
Coxeter, P, Del Mar, CB, McGregor, L, et al (2015) Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database of Systematic Reviews, 11: CD010907.
David, A, Adams, CE, Quraishi, SN (1999) Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders. Cochrane Database of Systematic Reviews, 2: CD001470.
Dowrick, C, Frances, A (2013) Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit. BMJ, 347: f7140.
Fusar-Poli, P, Bonoldi, I, Yung, AR, et al (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry, 69: 220–9.
Gray, JAM (2011) How to Get Better Value Healthcare.
Hersch, J, Barratt, A, Jansen, J, et al (2015) Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet, 385: 1642–52.
Hoffman, A, Pearson, SD (2009) “Marginal medicine”: targeting comparative effectiveness research to reduce waste. Health Affairs, 28: w710–8.
Jerant, A, Kravitz, RL, Garcia, EY (2014) Potential antidepressant overtreatment associated with office use of brief depression symptom measures. Journal of the American Board of Family Medicine, 27: 611–20.
Kmietowicz, Z (2015) Whether screening for ovarian cancer saves lives is still unclear despite large trial. BMJ, 351: h6876.
MacArthur, H, Phillips, C, Simpson, H (2012) Improving Quality Reduces Costs: Quality as the Business Strategy.
Mahapatra, J, Quraishi, SN, David, A, Sampson, S, Adams, CE (2014) Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders. Cochrane Database of Systematic Reviews, 6: CD001470.
Malhotra, A, Maughan, D, Ansell, J, et al (2015) Choosing Wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicine. BMJ, 350: h2308.
Maughan, DL, Lillywhite, R, Cooke, M (2016) Cost and carbon burden of long-acting injections: a sustainable evaluation. BJPsych Bulletin, 40: 132–6.
McCaffery, KJ, Jansen, J, Scherer, LD, et al (2016) Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ, 352: i348.
McCarthy, M (2013) ADHD drug makers move to expand into adult market. BMJ, 347: f7581.
McCarthy, M (2015) US Choosing Wisely campaign has had only modest success, study finds. BMJ, 351: h5437.
Mental Health Foundation (2005) Up and Running? Exercise Therapy and the Treatment of Mild or Moderate Depression in Primary Care.
Mental Health Foundation.
Moynihan, R, Smith, R (2002) Too much medicine? Almost certainly. BMJ, 324: 859–60.
Moynihan, R, Glasziou, P, Woloshin, S, et al (2013) Winding back the harms of too much medicine. BMJ, 346: f1271.
Moynihan, R (2015) Preventing overdiagnosis: the myth, the music, and the medical meeting. BMJ, 350: h1370.
Mulley, A, Trimble, C, Elwyn, G (2012) Patients' Preferences Matter: Stop the Silent Misdiagnosis.
National Collaborating Centre for Mental Health (2007) Dementia: The NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care
. British Psychological Society and Gaskell.
Polyak, A, Kubina, RM, Girirajan, S (2015) Comorbidity of intellectual disability confounds ascertainment of autism: implications for genetic diagnosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168:600–8.
Porter, ME (2010) What is value in health care?
New England Journal of Medicine, 363: 2477–81.
Public Health England (2015) The NHS Atlas of Variation in Healthcare: Reducing Unwarranted Variation to Increase Value and Improve Quality.
Public Health England.
Reed, P, Fanshawe, T (2011) The effects of dose of flupentixol decanoate on relapse rates in schizophrenia. The Psychiatrist, 35: 293–6.
Rosenberg, A, Agiro, A, Gottlieb, M, et al (2015) Early trends among seven recommendations from the Choosing Wisely campaign. JAMA Internal Medicine, 175: 1913–20.
Savitz, AW (2013) The Triple Bottom Line: How Today's Best-Run Companies are Achieving Economic, Social and Environmental Success and How You Can Too.
John Wiley & Sons.
Stacey, D, Légaré, F, Col, NF, et al (2014) Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 1: CD001431.
Steen-Olsen, K, Weinzettel, J, Cranston, G, et al (2012) Carbon, land, and water footprint accounts for the European Union: consumption, production, and displacements through international trade. Environmental Science & Technology, 46: 10883–91.
Sustainable Development Unit (2013) Carbon Footprint Update for NHS in England 2012.
Wakefield, JC, First, MB (2012) Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5?
World Psychiatry, 11: 3–10.
Welch, HG, Schwartz, L, Woloshin, S (2011) Overdiagnosed: Making People Sick in the Pursuit of Health.
Wolfson, D, Santa, J, Slass, L (2014) Engaging physicians and consumers in conversations about treatment overuse and waste. Academic Medicine, 89: 990–5.